Oppenheimer Maintains CEVA Inc(CEVA.US) With Buy Rating, Raises Target Price to $36
CEVA Price Target Raised to $35.00/Share From $31.00 by Northland Capital Markets
CEVA Is Maintained at Outperform by Northland Capital Markets
CEVA Analyst Ratings
Roth MKM Maintains CEVA Inc(CEVA.US) With Buy Rating, Raises Target Price to $40
Rosenblatt Securities Maintains CEVA Inc(CEVA.US) With Buy Rating, Raises Target Price to $35
Barclays Maintains CEVA Inc(CEVA.US) With Buy Rating, Maintains Target Price $34
Barclays Maintains CEVA Inc(CEVA.US) With Buy Rating, Raises Target Price to $34
Barclays Raises Price Target on CEVA to $34 From $29, Maintains Overweight Rating
CEVA Analyst Ratings
Rosenblatt Maintains Buy on CEVA, Maintains $28 Price Target
Northland Securities Maintains CEVA Inc(CEVA.US) With Buy Rating, Maintains Target Price $31
Northland Securities Maintains CEVA Inc(CEVA.US) With Buy Rating, Maintains Target Price $31
Ceva Upgraded to 'Buy' at Roth MKM on Improving Royalty Recovery, Refocus Efforts
Analysts Offer Insights on Technology Companies: Ceva (CEVA), Audinate Group Ltd. (OtherAUDGF) and Docebo (DCBO)
CEVA Analyst Ratings
Roth MKM Upgrades CEVA to Buy, Raises Price Target to $25
Barclays Sticks to Its Buy Rating for Ceva (CEVA)
CEVA Analyst Ratings
Oppenheimer Remains a Buy on Ceva (CEVA)